Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/25155
Title: Everolimus safety and efficacy for renal angiomyolipomas associated with tuberous sclerosis complex: a Spanish expanded access trial.
Authors: 
Keywords: 
Issue Date: 26-Sep-2016
Citation: Orphanet J Rare Dis.2016 Sep;(11)1:128
Abstract: Renal angiomyolipomas (AML) are usual manifestations of tuberous sclerosis complex (TSC) that may cause aneurism-related haemorrhages and renal impairment. Everolimus has emerged as an alternative to surgery/embolization. We provide further insight into everolimus safety and efficacy for TSC-related AML.
PMID: 27669821
URI: https://hdl.handle.net/20.500.12530/25155
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos

Files in This Item:
File Description SizeFormat 
PMC5037621.pdf499.74 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.